Anonymous ID: 861ee2 Jan. 23, 2025, 8:35 a.m. No.22418716   🗄️.is 🔗kun   >>8745

can someone post or find a link to the actual FDA announcement approving SPRAVATO nasal spray for 2025? All I could find was an announcement from 2019 about it and with the blackout that just dropped on them Tuesday…where is the source of this announcement? pharma mags and J&J and MSM seem to be the only sources. FDA has not updated its announcements.

Anonymous ID: 861ee2 Jan. 23, 2025, 8:40 a.m. No.22418745   🗄️.is 🔗kun   >>8762

>>22418716

announcement from 2019

 

https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified

 

"Patients with major depressive disorder who, despite trying at least two antidepressant treatments given at adequate doses for an adequate duration in the current episode, have not responded to treatment are considered to have treatment-resistant depression.

 

The Spravato labeling contains a Boxed Warning that cautions that patients are at risk for sedation and difficulty with attention, judgment and thinking (dissociation), abuse and misuse, and suicidal thoughts and behaviors after administration of the drug. Because of the risk of sedation and dissociation, patients must be monitored by a health care provider for at least two hours after receiving their Spravato dose. The REMS requires the prescriber and the patient to both sign a Patient Enrollment Form that clearly states that the patient understands they should make arrangements to safely leave the health care setting to get home and that the patient should not drive or use heavy machinery for the rest of the day on which they received the drug. Additionally, Spravato must be dispensed with a patient Medication Guide that outlines the drug’s uses and risks."

 

what is going on?